Depression therapy optimization at the present stage of development of psychopharmacology

Depression therapy optimization at the present stage of development of psychopharmacology

The paper presents current psychopharmacological approaches to therapy for depressions. It discusses the efficacy of depressants with a monoaminergic mechanism of action. Whether combination therapy with antidepressants and drugs from other pharmacological groups may be used is considered. Separate...

Full description

Bibliographic Details
Main Author: Dmitry Sergeyevich Danilov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2013-03-01
Series:Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Subjects:
antidepressants
mechanism of action
depression
pathogenesis
gabaergic agents
alprazolam
Online Access:https://nnp.ima-press.net/nnp/article/view/172
id doaj-8d023c8050914307850d7593b7d451b3
record_format Article
spelling doaj-8d023c8050914307850d7593b7d451b32021-07-29T08:58:34ZrusIMA-PRESS LLCNevrologiâ, Nejropsihiatriâ, Psihosomatika2074-27112310-13422013-03-0151222710.14412/2074-2711-2013-2393172Depression therapy optimization at the present stage of development of psychopharmacologyDmitry Sergeyevich DanilovThe paper presents current psychopharmacological approaches to therapy for depressions. It discusses the efficacy of depressants with a monoaminergic mechanism of action. Whether combination therapy with antidepressants and drugs from other pharmacological groups may be used is considered. Separate attention is paid to the agents whose antidepressant effect is unrelated to their action on the monoaminergic system.https://nnp.ima-press.net/nnp/article/view/172antidepressantsmechanism of actiondepressionpathogenesisgabaergic agentsalprazolam
collection DOAJ
language Russian
format Article
sources DOAJ
author Dmitry Sergeyevich Danilov
spellingShingle Dmitry Sergeyevich Danilov
Depression therapy optimization at the present stage of development of psychopharmacology
Nevrologiâ, Nejropsihiatriâ, Psihosomatika
antidepressants
mechanism of action
depression
pathogenesis
gabaergic agents
alprazolam
author_facet Dmitry Sergeyevich Danilov
author_sort Dmitry Sergeyevich Danilov
title Depression therapy optimization at the present stage of development of psychopharmacology
title_short Depression therapy optimization at the present stage of development of psychopharmacology
title_full Depression therapy optimization at the present stage of development of psychopharmacology
title_fullStr Depression therapy optimization at the present stage of development of psychopharmacology
title_full_unstemmed Depression therapy optimization at the present stage of development of psychopharmacology
title_sort depression therapy optimization at the present stage of development of psychopharmacology
publisher IMA-PRESS LLC
series Nevrologiâ, Nejropsihiatriâ, Psihosomatika
issn 2074-2711
2310-1342
publishDate 2013-03-01
description The paper presents current psychopharmacological approaches to therapy for depressions. It discusses the efficacy of depressants with a monoaminergic mechanism of action. Whether combination therapy with antidepressants and drugs from other pharmacological groups may be used is considered. Separate attention is paid to the agents whose antidepressant effect is unrelated to their action on the monoaminergic system.
topic antidepressants
mechanism of action
depression
pathogenesis
gabaergic agents
alprazolam
url https://nnp.ima-press.net/nnp/article/view/172
work_keys_str_mv AT dmitrysergeyevichdanilov depressiontherapyoptimizationatthepresentstageofdevelopmentofpsychopharmacology
_version_ 1721250731082645504

Similar Items